{"id":"https://openalex.org/W2556767910","doi":"https://doi.org/10.1182/blood.v114.22.3696.3696","title":"A Phase I Study of Vorinostat (V) in Combination with Rituximab (R), Ifosphamide, Carboplatin, and Etoposide (ICE) for Patients with Relapsed or Refractory Lymphoid Malignancies or Untreated T- or Mantle Cell Lymphoma.","display_name":"A Phase I Study of Vorinostat (V) in Combination with Rituximab (R), Ifosphamide, Carboplatin, and Etoposide (ICE) for Patients with Relapsed or Refractory Lymphoid Malignancies or Untreated T- or Mantle Cell Lymphoma.","publication_year":2009,"publication_date":"2009-11-20","ids":{"openalex":"https://openalex.org/W2556767910","doi":"https://doi.org/10.1182/blood.v114.22.3696.3696","mag":"2556767910"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v114.22.3696.3696","doi":"https://doi.org/10.1182/blood.v114.22.3696.3696","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v114.22.3696.3696","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082326885","display_name":"Lihua Elizabeth Budde","orcid":"https://orcid.org/0000-0003-1464-5494","observed_orcids":["https://orcid.org/0000-0003-1464-5494"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lihua E. Budde","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA,","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033430277","display_name":"Michelle M. Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106811","display_name":"Valley Medical Center","ror":"https://ror.org/01vjngb81","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106811"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michelle M. Zhang","raw_affiliation_strings":["Southlake Clinic, Valley Medical Center, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Southlake Clinic, Valley Medical Center, Seattle, WA, USA,","institution_ids":["https://openalex.org/I4210106811"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059661907","display_name":"Andrei R. Shustov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrei R. Shustov","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA,","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040412322","display_name":"John M. Pagel","orcid":"https://orcid.org/0000-0001-5745-8125","observed_orcids":["https://orcid.org/0000-0001-5745-8125","https://orcid.org/0000-0003-2875-4878"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John M. Pagel","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA,","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058377779","display_name":"Thomas A. Warr","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas A. Warr","raw_affiliation_strings":["Clinic Cancer Care, Great Falls, MT, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic Cancer Care, Great Falls, MT, USA,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008481093","display_name":"Tara L. Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1332479046","display_name":"Seattle Cancer Care Alliance","ror":"https://ror.org/03jq88n71","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1332479046"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Tara L Chen","raw_affiliation_strings":["Seattle Cancer Care Alliance, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Cancer Care Alliance, Seattle, WA, USA,","institution_ids":["https://openalex.org/I1332479046"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103707313","display_name":"George R. Oliveira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"George R. Oliveira","raw_affiliation_strings":["Dept. of Radiology, University of Washington, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Radiology, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023949296","display_name":"Ted Alan Gooley","orcid":"https://orcid.org/0000-0002-8182-3652","observed_orcids":["https://orcid.org/0000-0002-8182-3652"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ted Gooley","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA,","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004025497","display_name":"Ajay K. Gopal","orcid":"https://orcid.org/0000-0003-3023-6834","observed_orcids":["https://orcid.org/0000-0003-3023-6834"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajay K. Gopal","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA,","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5008481093","https://openalex.org/A5023949296","https://openalex.org/A5033430277","https://openalex.org/A5103707313"],"corresponding_institution_ids":["https://openalex.org/I1332479046","https://openalex.org/I201448701","https://openalex.org/I4210089486","https://openalex.org/I4210106811"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.9328,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.78293286,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"114","issue":"22","first_page":"3696","last_page":"3696"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vorinostat","display_name":"vorinostat","score":0.9980000257492065},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.8450000286102295},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9350000023841858},{"id":"https://openalex.org/keywords/ifosfamide","display_name":"ifosfamide","score":0.9419999718666077},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.996999979019165},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":1.0},{"id":"https://openalex.org/keywords/ice-regimen","display_name":"ICE regimen","score":0.7059999704360962},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.8830000162124634},{"id":"https://openalex.org/keywords/t-cell-lymphoma","display_name":"T-cell lymphoma","score":0.9200000166893005},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9909999966621399},{"id":"https://openalex.org/keywords/hodgkin-lymphoma","display_name":"Hodgkin's disease","score":0.8650000095367432},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7720000147819519},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7590000033378601},{"id":"https://openalex.org/keywords/hematopoietic-recovery","display_name":"hematopoietic recovery","score":0.625},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.3160000145435333}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7682749032974243},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.6998617649078369},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6396294236183167},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6344504356384277},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46763017773628235},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.4673125445842743},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.46011167764663696},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.4394304156303406},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.42958641052246094},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.41028547286987305},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.3732464909553528},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.26496511697769165}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v114.22.3696.3696","doi":"https://doi.org/10.1182/blood.v114.22.3696.3696","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v114.22.3696.3696","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2591855899","https://openalex.org/W2022625652","https://openalex.org/W2583559553","https://openalex.org/W2143161378","https://openalex.org/W2601261981","https://openalex.org/W2264597658","https://openalex.org/W2891826085","https://openalex.org/W2103461425","https://openalex.org/W2346665543","https://openalex.org/W2231159507"],"abstract_inverted_index":{"Abstract":[0,1],"3696":[2],"Poster":[3],"Board":[4],"III-632":[5],"Platinum":[6],"based":[7],"regimens":[8],"such":[9],"as":[10,82,84,217],"ICE":[11,112,294],"with":[12,54,109,118,195,290,470,493,498,503,543,553],"or":[13,24,111,114,120,124,127,231,237,261,293,476,545,579],"without":[14],"Rituximab":[15],"(RICE)":[16],"have":[17,308],"been":[18,309],"widely":[19],"used":[20],"to":[21,29,40,257,280,286,298,328,430,561,585,691],"treat":[22],"relapsed":[23,119,395],"refractory":[25,121,391],"lymphoid":[26,122,554],"malignancies":[27,123],"prior":[28,374,383,387],"transplantation.":[30],"However,":[31],"a":[32,62,90,200],"significant":[33],"portion":[34],"of":[35,64,103,140,155,183,210,246,250,254,267,273,305,373,407,421,444,461,517,541,564,571,577,592,689],"patients":[36,117,307,447,453,464,488,519,552],"do":[37],"not":[38],"respond":[39],"treatment,":[41],"and":[42,57,79,138,169,324,350,481,501,511,549,594],"improved":[43],"therapies":[44,375],"are":[45],"needed.":[46],"Vorinostat":[47],"(V)":[48],"is":[49,205,547],"an":[50,151],"oral":[51],"HDAC":[52],"inhibitor":[53],"moderate":[55],"toxicity":[56,203,258],"has":[58,424],"clinical":[59],"activity":[60,137],"against":[61],"variety":[63],"tumors":[65],"including":[66,491],"cutaneous":[67],"T":[68],"cell":[69,145,338,344,526],"lymphoma.":[70],"Preclinical":[71],"data":[72,88],"demonstrated":[73],"marked":[74],"anti-tumor":[75,136],"synergism":[76],"between":[77],"V":[78,104,184,274,405],"platinum":[80,388],"analogues":[81],"well":[83],"etoposide.":[85],"We":[86],"present":[87],"from":[89,259,276,426],"phase":[91,574],"I,":[92],"open-label,":[93],"multicenter,":[94],"dose":[95,102,201,406,418,598],"escalation":[96],"study":[97,313],"estimating":[98],"the":[99,188,244,265,268,436,449,539,562,565,572],"maximally":[100],"tolerated":[101],"that":[105,242,538],"can":[106],"be":[107,559,583],"combined":[108],"RICE":[110,292,544],"(V-RICE":[113],"VICE)":[115],"in":[116,288,317,321,413,479,485,551],"untreated":[125,399],"T-":[126],"Mantle":[128],"Cell":[129],"Lymphoma.":[130],"Other":[131],"endpoints":[132],"include":[133],"tolerability,":[134],"exploratory":[135],"impact":[139],"above":[141],"regimen":[142,581],"on":[143,175,180,295,311],"stem":[144,525],"reserve.":[146],"Patients":[147],"(aged":[148],"\u226518":[149],"years,":[150],"ECOG":[152],"performance":[153],"status":[154],"0-2,":[156],"measurable":[157],"disease,":[158],"no":[159,172],"active":[160,173,550],"central":[161],"nervous":[162],"system":[163],"involvement,":[164],"adequate":[165],"bone":[166],"marrow,":[167],"hepatic":[168],"renal":[170],"function,":[171],"arrhythmias":[174],"EKG)":[176],"were":[177,530],"sequentially":[178],"enrolled":[179,310],"escalating":[181],"doses":[182],"combination":[185,289,540],"therapy":[186,251],"using":[187],"\u201ctwo":[189],"stage\u201d":[190],"design":[191],"introduced":[192],"by":[193,208],"Storer":[194],"single":[196],"patient":[197,507],"cohorts":[198,209],"until":[199],"limiting":[202],"(DLT)":[204],"observed,":[206],"followed":[207],"4":[211,236,483,633,664,670],"patients.":[212],"A":[213,303,403],"DLT":[214],"was":[215,411],"defined":[216],"any":[218,232,240,262],"gastrointestinal":[219,567],"grade":[220,235,468,482],"3":[221,297,469,625,665],"NCI-CTCAE":[222],"adverse":[223],"event":[224,241],"(AE)":[225],"lasting":[226],"longer":[227],"than":[228],"7":[229],"days,":[230],"related":[233],"non-hematologic":[234,466],"5":[238,287,299,381,393,643,660,682],"AE;":[239],"prevents":[243],"completion":[245],"one":[247,512],"full":[248],"cycle":[249,443],"(5":[252],"days":[253,284,296],"V)":[255],"due":[256],"V;":[260],"AE":[263],"at":[264,596],"discretion":[266],"principal":[269],"investigator.":[270],"Therapy":[271],"consisted":[272],"ranging":[275],"400":[277,431,609,626],"mg":[278,282,409,428,432,610,619,627,635,645,653,662,672],"daily":[279],"700":[281,408,652],"BID":[283,410,429,433,620,628,636,646,654,663,673],"1":[285,401,492,608,621,629,647,656,674,675],"standard":[291],"every":[300],"21":[301],"days.":[302],"total":[304],"18":[306],"this":[312],"thus":[314],"far":[315],"(9":[316],"stage":[318,322,367,414,422],"1,":[319],"9":[320,502],"2)":[323],"14are":[325],"fully":[326],"evaluable":[327,438],"date,":[329],"including:":[330],"Hodgkin":[331],"lymphoma":[332,335,339,345,348],"(4),":[333],"T-cell":[334],"(3);":[336],"mantle":[337],"(2);":[340,346],"diffuse":[341],"large":[342],"B":[343],"follicular":[347],"(2),":[349],"chronic":[351],"lymphocytic":[352],"leukemia":[353],"(1).":[354],"Baseline":[355],"characteristics":[356],"(n=14)":[357],"included:":[358],"median":[359,371],"age":[360],"55":[361],"(range:":[362,377],"33-67),":[363],"male":[364],"10":[365],"(71%),":[366],"III/IV":[368],"14":[369,437,462,681],"(100%),":[370],"number":[372],"2":[376,389,458,497,612,617,637,655],"0-6),":[378],"elevated":[379],"LDH":[380],"(35%),":[382],"anthracycline":[384],"13":[385],"(93%),":[386],"(14%),":[390],"diseases":[392,396],"(36%),":[394],"8":[397,456],"(57%),":[398],"disease":[400,510,514],"(7%).":[402],"maximum":[404],"attained":[412],"I":[415,607],"(Table).":[416],"The":[417],"adjustment":[419],"schema":[420],"II":[423,575,659],"ranged":[425],"600":[427,644,661],"currently.":[434],"Among":[435],"patients,":[439],"six":[440],"received":[441],"only1":[442],"treatment":[445],"(3/5":[446],"declined":[448],"second":[450],"cycle;":[451],"2/5":[452],"developed":[454],"DLT),":[455],"completed":[457],"cycles.":[459],"Eight":[460],"(57%)":[463],"experienced":[465],"AEs\u2265":[467],"most":[471],"common":[472],"being":[473],"nausea,":[474],"vomiting,":[475],"diarrhea":[477],"seen":[478],"6":[480,651],"hypokalemia":[484],"2.":[486],"Twelve":[487],"(86%)":[489,684],"responded":[490],"complete":[494],"remission":[495],"(CR),":[496],"unconfirmed":[499],"CR,":[500],"partial":[504],"responses.":[505],"One":[506],"had":[508,513],"stable":[509],"progression.":[515],"Nine":[516],"12":[518,683],"(75%)":[520],"who":[521],"attempted":[522],"peripheral":[523],"blood":[524],"collection":[527],"following":[528],"VICE/V-RICE":[529],"successful":[531],"(>5\u00d7106":[532],"CD34+/kg)":[533],"Collectively,":[534],"these":[535],"findings":[536],"indicate":[537],"vorinostat":[542],"ICE,":[546],"feasible":[548],"malignancies.":[555],"Special":[556],"attention":[557],"should":[558],"given":[560],"management":[563],"frequent":[566],"AEs.":[568],"Pending":[569],"identification":[570],"MTD,":[573],"evaluation":[576],"VICE":[578],"V-RICE":[580],"will":[582],"designed":[584],"formally":[586],"define":[587],"its":[588],"efficacy.":[589],"Table":[590],"Summary":[591],"DLTs":[593,605],"responses":[595,606],"various":[597],"levels":[599],"Stage":[600],"Dose":[601,603],"level":[602],"n":[604],"QD":[611],"0":[613,622,630,638,648],"PR(1);":[614],"SD":[615],"(1)":[616,624,632,642,650,677],"300":[618],"PR":[623,639,649,657,666,676],"PD":[631],"500":[634,671],"(1);":[640,667],"CR":[641],"(2)":[658],"CRu":[668],"(3)":[669],"Total":[678],"-":[679,680],"Disclosures:":[685],"No":[686],"relevant":[687],"conflicts":[688],"interest":[690],"declare.":[692]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-11-30T00:00:00"}